Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process─Part 3
In campaign 1, 124.3 kg of 2-methyl-5-(2H-1,2,3-triazol-2-yl)pyridine N-oxide (8) was prepared in 2 stages from 5-bromo-2-methylpyridine. The first stage was a regioselective copper-catalyzed Ullmann reaction using 1H-1,2,3-triazole. The second stage was an oxidation with peracetic acid to form the corresponding pyridine N-oxide. In campaign 2, 223.8 kg of 2-methyl-5-(2H-1,2,3-triazol-2-yl)pyridine N-oxide (8) was prepared. An alternative palladium-catalyzed Buchwald−Hartwig approach using Me4tBuXPhos as a ligand was developed but not scaled up. 2-Methyl-5-(2H-1,2,3-triazol-2-yl)pyridine N-oxide (8) is a key intermediate in the synthesis of the orexin 1 receptor antagonist C4X3256.
Authors
- Jonathan C. Churchill (ORCID: https://orcid.org/0000-0003-4464-2702)
- Paul Leong
- John S Carey (ORCID: https://orcid.org/0000-0002-3654-0063)
Institutions
- The Priory Hospital (GB)
- Lonza (Switzerland) (CH)
Publication Details
- Journal
- Organic Process Research & Development
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1021/acs.oprd.6c00298
- Citations
- 3
- Primary Topic
- Catalytic Cross-Coupling Reactions
- Type
- article
- Field-Weighted Citation Impact
- 3.78